4-Aminoquinoline

4-Aminoquinoline
Names
	Preferred IUPAC name Quinolin-4-amine
Identifiers
CAS Number	578-68-7 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL58146 ;
ChemSpider	61751 ;
ECHA InfoCard	100.167.771
PubChem CID	68476;
UNII	GTE5P5L97N ;
CompTox Dashboard (EPA)	DTXSID70206491 ;
	InChI InChI=1S/C9H8N2/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H2,10,11) Key: FQYRLEXKXQRZDH-UHFFFAOYSA-N ;
	SMILES n1ccc(c2ccccc12)N;
Properties
Chemical formula	C9H8N2
Molar mass	144.177 g·mol−1
Appearance	Powder to crystalline, White/Yellow/Orange
Melting point	151.0 to 155.0 °C
Hazards
	Occupational safety and health (OHS/OSH):
Main hazards	Causes skin and serious eye irritation
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. The compound has been used as a precursor for the synthesis of its derivatives.^[1]

A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections.^[2] Examples include amodiaquine, chloroquine, and hydroxychloroquine.^[3] Other uses for the derivatives are: anti-asthmatic, antibacterial, anti-fungal, anti-malarial, antiviral and anti-inflammatory agents. ^[1]

A patent application for 4-aminoquinoline compounds was filed in 2002 and published in 2005.^[4]

^ ^a ^b Al-Ahmary KM, Alenezi MS, Habeeb MM (2016-08-01). "Synthesis, spectroscopic and DFT theoretical studies on the hydrogen bonded charge transfer complex of 4-aminoquinoline with chloranilic acid". Journal of Molecular Liquids. 220: 166–182. doi:10.1016/j.molliq.2016.04.074. ISSN 0167-7322.
^ Bosak A, Opsenica DM, Šinko G, Zlatar M, Kovarik Z (2019-08-01). "Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase". Chemico-Biological Interactions. 308: 101–109. Bibcode:2019CBI...308..101B. doi:10.1016/j.cbi.2019.05.024. ISSN 0009-2797. PMID 31100281. S2CID 157067252.
^ Bray PG, Hawley SR, Ward SA (1996). "4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake". Mol. Pharmacol. 50 (6): 1551–8. PMID 8967977.
^ DeVita R, Chang L (13 January 2005). "4-Aminoquinoline Compounds" (PDF). United States Patent Application Publication.

[:0-1] Al-Ahmary KM, Alenezi MS, Habeeb MM (2016-08-01). "Synthesis, spectroscopic and DFT theoretical studies on the hydrogen bonded charge transfer complex of 4-aminoquinoline with chloranilic acid". Journal of Molecular Liquids. 220: 166–182. doi:10.1016/j.molliq.2016.04.074. ISSN 0167-7322.

[2] Bosak A, Opsenica DM, Šinko G, Zlatar M, Kovarik Z (2019-08-01). "Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase". Chemico-Biological Interactions. 308: 101–109. Bibcode:2019CBI...308..101B. doi:10.1016/j.cbi.2019.05.024. ISSN 0009-2797. PMID 31100281. S2CID 157067252.

[pmid8967977-3] Bray PG, Hawley SR, Ward SA (1996). "4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake". Mol. Pharmacol. 50 (6): 1551–8. PMID 8967977.

[4] DeVita R, Chang L (13 January 2005). "4-Aminoquinoline Compounds" (PDF). United States Patent Application Publication.

[1]

[2]

[3]

[4]